Oregon Cancer
News and information for cancer services throughout Oregon.
-
Read ArticleHonoring our physicians on Doctors’ Day
In honor of Doctors' Day on March 30, we recognize the significant contributions of physicians and their commitment to providing the most advanced, highest quality care for our cancer patients.
-
Read ArticleTargeted therapies are the focus of new studies for colorectal and bile duct cancers
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
-
Read ArticleCelebrating our oncology social workers
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
-
Read ArticleCancer vaccine is focus of breast cancer study at Providence
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
-
Read ArticleAACR Project GENIE: Making an impact worldwide in cancer research and precision medicine
As part of an international data-sharing consortium of leading cancer centers, Providence Cancer Institute and Swedish Cancer Institute work together to provide genomic data to Project GENIE.
-
Read ArticleMRI-guided radiotherapy is a gamechanger in treating prostate cancer
Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
-
Read ArticleNew study opens for non-GCB DLBCL patients under age 70
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
-
Read ArticleCelebrating a year of community engagement
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
-
Read ArticleThree phases of clinical trials round out a year of research advancements
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
-
Read ArticleFellowship trains next generation of immuno-oncology experts
Providence currently accepting applications for an Immuno-Oncology Research Fellowship being offered through Earle A. Chiles Research Institute.
-
Read ArticleProvidence immunologist honored at leading cancer conference
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.
-
Read ArticleLearn how integrative medicine can improve quality of life for cancer patients
Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.
-
Read ArticleProvidence among few sites worldwide offering new trials for solid tumors and lung cancer
Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.
-
Read ArticleThree new studies are focus of Breast Cancer Awareness Month
Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.
-
Read ArticleProvidence lung cancer experts to present at oncology summit
Leading lung cancer professionals to gather in November for premier oncology summit.
-
Read ArticleMedical expert shares promising treatments and latest research for gynecologic cancers
Providence gynecologic oncologist Christopher Darus, M.D. shares the latest research and promising treatments for gynecologic cancers.
-
Read ArticleUnderstanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin
Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.
-
Read ArticleNew trial is first to study targeted therapy combination for treating thyroid cancer
New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.
-
Read ArticleProvidence Cancer Institute shares updates on advances in care for melanoma patients
Providence Cancer Institute experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a virtual symposium.
-
Read ArticleShorter treatment duration with new therapy is focus of rectal cancer trial
New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer
-
Loading More...
